Specialty Products Bring Distribution Challenges and Opportunities

AUGUST 22, 2011
Specialty products now represent a $100 billion industry. At CBI’s 2nd Annual Forum on Strategic Distribution Planning for Specialty Products, Gina Clarke, Chief Marketing Officer, AmerisourceBergen, offers a snapshot of the specialty market as well as the segments that are poised for growth—those therapeutic areas that have achieved the greatest commercial success over the past five years.

This September 22–23, attendees come together in Philadelphia to discuss strategies that will ensure pull through and increase product usage:
  • Examine underlying reasons in your product that influence distribution strategies for specialty products. Learn more, click here.
  • Discuss factors that drive the choice to have an open, limited or closed distribution network. Ensure your edge, click here.
The complex distribution of specialty pharmaceuticals dominates the responsibilities of many senior-level executives, such as those in trade and distribution, commercial operations, and marketing. With a strong agenda filled with practical strategies, Strategic Distribution Planning for Specialty Products offers valuable insight on trends and tactics to ensure access, use and reimbursement of this growing market segment.


5 Studies That Shaped HIV Treatment That Every Pharmacist Should Know
Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today.



Conference Coverage
News from the year's biggest meetings

Pharmacist Education
Clinical features with downloadable PDFs


Personalize the information you receive by selecting targeted content and special offers.